Literature DB >> 15021221

Risk and risk factors for blindness from glaucoma.

Philip P Chen1.   

Abstract

PURPOSE OF REVIEW: Estimates of blindness from glaucoma and risk factors for blindness remain of interest for all ophthalmologists. RECENT
FINDINGS: Long-term retrospective studies of patients with open-angle glaucoma in developed countries have noted that progression to bilateral blindness among treated patients is relatively uncommon. Risk factors for development of blindness include advanced visual field loss at presentation and noncompliance with the treatment regimen. Age is a risk factor in some studies. Many of those with blindness are blind at presentation. Untreated rates of blindness are higher. Population-based studies of glaucoma in developing countries have highlighted the obstacles to prevention of blindness in such settings, with astonishingly high rates of blindness noted.
SUMMARY: The risk of blindness from glaucoma is very high among patients in developing countries, the vast majority of whom do not know they are afflicted. When considering all glaucoma worldwide, the greatest risk factor for blindness is almost certainly being an average citizen of a developing country. Among those with open-angle glaucoma in developed countries, more advanced visual field loss at presentation and noncompliance are risk factors for development of blindness, as well as advanced age. Effective public education about glaucoma and targeted screening of those most likely to have glaucoma are necessary if the number of blind from glaucoma is to be reduced worldwide. Better treatment options for those in developing countries must also be developed.

Entities:  

Mesh:

Year:  2004        PMID: 15021221     DOI: 10.1097/00055735-200404000-00009

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  16 in total

1.  Glaucoma in the developing world.

Authors:  Mahesh Ramchandani
Journal:  BMJ       Date:  2006-11-04

2.  Choroidal blood flow decreases with age: an MRI study.

Authors:  Oscar San Emeterio Nateras; Joseph M Harrison; Eric R Muir; Yi Zhang; Qi Peng; Steven Chalfin; Juan E Gutierrez; Daniel A Johnson; Jeffrey W Kiel; Timothy Q Duong
Journal:  Curr Eye Res       Date:  2014-03-21       Impact factor: 2.424

3.  Large Disparities in Receipt of Glaucoma Care between Enrollees in Medicaid and Those with Commercial Health Insurance.

Authors:  Angela R Elam; Chris Andrews; David C Musch; Paul P Lee; Joshua D Stein
Journal:  Ophthalmology       Date:  2017-06-02       Impact factor: 12.079

4.  Managing glaucoma in developing countries.

Authors:  Mauro Toledo Leite; Lisandro Massanori Sakata; Felipe Andrade Medeiros
Journal:  Arq Bras Oftalmol       Date:  2011 Mar-Apr       Impact factor: 0.872

5.  Cost of cataract surgery after implantation of three intraocular lenses.

Authors:  Catherine Boureau; Antoine Lafuma; Viviane Jeanbat; Andrew F Smith; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2009-06-02

6.  Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database.

Authors:  Renato De Natale; Antoine Lafuma; Gilles Berdeaux
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

7.  Glaucoma Blindness at a Tertiary Eye Care Center.

Authors:  Jordan S Stone; Kelly W Muir; Sandra S Stinnett; Jullia A Rosdahl
Journal:  N C Med J       Date:  2015 Sep-Oct

8.  Evidence base for an intervention to maximise uptake of glaucoma testing: a theory-based cross-sectional survey.

Authors:  Maria Prior; Jennifer M Burr; Craig R Ramsay; David Jenkinson; Susan Campbell; Jillian J Francis
Journal:  BMJ Open       Date:  2012-03-01       Impact factor: 2.692

9.  Determinants for late presentation of glaucoma among adult glaucomatous patients in University of Gondar Comprehensive Specialized Hospital. Case-control study.

Authors:  Biruktayit Kefyalew Belete; Natnael Lakachew Assefa; Abel Sinshaw Assem; Fisseha Admasu Ayele
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

10.  Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics.

Authors:  Luca Rossetti; Maurizio Digiuni; Giovanni Montesano; Montesano Giovanni; Marco Centofanti; Antonio M Fea; Michele Iester; Paolo Frezzotti; Michele Figus; Antonio Ferreras; Francesco Oddone; Lucia Tanga; Teresa Rolle; Valentina Battaglino; Chiara Posarelli; Ilaria Motolese; Pietro Mittica; Simone Alex Bagaglia; Cristina Menicacci; Stefano De Cilla'; Alessandro Autelitano; Paolo Fogagnolo
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.